Bacterial serine protease HtrA as a promising new target for antimicrobial therapy?

45Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent studies have demonstrated that the bacterial chaperone and serine protease high temperature requirement A (HtrA) is closely associated with the establishment and progression of several infectious diseases. HtrA activity enhances bacterial survival under stress conditions, but also has direct effects on functions of the cell adhesion protein E-cadherin and extracellular matrix proteins, including fibronectin and proteoglycans. Although HtrA cannot be considered as a pathogenic factor per se, it exhibits favorable characteristics making HtrA a potentially attractive drug target to combat various bacterial infections.

Cite

CITATION STYLE

APA

Wessler, S., Schneider, G., & Backert, S. (2017, January 10). Bacterial serine protease HtrA as a promising new target for antimicrobial therapy? Cell Communication and Signaling. BioMed Central Ltd. https://doi.org/10.1186/s12964-017-0162-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free